SP

Shankar Pattanayak Shreeram

Active Director Director DIN 11498360
DIN 11498360 First appointment Jan 2026 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Shankar Pattanayak Shreeram

Data last updated:

Shankar Pattanayak Shreeram is a Director at Healoid Healthtech Private Limited (since 2026). The company operates in Healthcare.

DIN 11498360
Primary Designation Director
Industry Healthcare
First Appointment 21 Jan 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Healoid Healthtech Private Limited U62099TS2026PTC210038
Director21 Jan 20262026Active

Board colleagues of Shankar Pattanayak Shreeram

NameDINCompanyDesignation
Saswati Pattanaik11498359Healoid Healthtech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Healoid Healthtech Private Limited
Premium access

Shareholding and investment profile for Shankar Pattanayak Shreeram

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shankar Pattanayak Shreeram

Shankar Pattanayak Shreeram currently holds 1 directorship: Healoid Healthtech Private Limited (Director, since 21 Jan 2026).

Shankar Pattanayak Shreeram was first appointed on 21 Jan 2026 as Director at Healoid Healthtech Private Limited.

The current boards of Shankar Pattanayak Shreeram's companies include Saswati Pattanaik (Healoid Healthtech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available